SciELO Analytics (Beta)
Brasil
Brazilian Journal of Medical and Biological Research (0100-879X)
Immunologic patterns associated with cure in human American cutaneous leishmaniasis

Received Citations (8)

publishing year previous first author document title
2011 Journal of Venomous Animals and Toxins including Tropical Diseases Almeida, AF Immunophenotypic characterization of patients with American cutaneous leishmaniasis prior to and after treatment in Pernambuco, Brazil
2004 Memórias do Instituto Oswaldo Cruz Silveira, Fernando T Clinical and immunopathological spectrum of American cutaneous leishmaniasis with special reference to the disease in Amazonian Brazil: a review
2000 Brazilian Journal of Medical and Biological Research Bertho, A.L. Detection of early apoptosis and cell death in T CD4+ and CD8+ cells from lesions of patients with localized cutaneous leishmaniasis
2001 Memórias do Instituto Oswaldo Cruz Toledo, VPCP Immunochemotherapy in American cutaneous leishmaniasis: immunological aspects before and after treatment
2006 Revista da Sociedade Brasileira de Medicina Tropical Mayrink, Wilson Imunoterapia, imunoquimioterapia e quimioterapia no tratamento da leishmaniose tegumentar americana
2004 Memórias do Instituto Oswaldo Cruz Souza-Neto, Sebastião Martins de Leishmania braziliensis: partial control of experimental infection by interleukin-12 p40 deficient mice
2015 Memórias do Instituto Oswaldo Cruz Ferraz, Raquel T-cell receptor Vβ repertoire of CD8+ T-lymphocyte subpopulations in cutaneous leishmaniasis patients from the state of Rio de Janeiro, Brazil
2000 Cadernos de Saúde Pública Davies, Clive Richard Epidemiologia e controle da leishmaniose nos países andinos
This tool is under development and it is available in Beta Test version
This tool is under development and it was published with the objective to test the usage and performance. All the indicators are real and they are gradually being loaded. Slowness and out of service problems may occur in this version.
Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.